Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations into mouse fetuses

Reproductive Toxicology

Volumn 10, Issue 5, 1996, Pages 345-363

  Padmanabhan, R ^a   Ahmed, Ijaz ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

axial skeletal defects; craniofacial anomalies; exencephaly; sodium valproate; TO mouse

Indexed keywords

ANIMALIA;

EID: 0030250887     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/0890-6238(96)00081-0     Document Type: Article

References (74)

1. 1. Yerbi MS. Pregnancy and epilepsy, Epilepsia. 1991;32:S51-S55.
2. 2. Kelly TE. Teratogenicity of anticonvulsant drugs. I: Review of the literature. Am J Med Genet. 1984;19:413-34.
3. 3. Meadow R. Anticonvulsants in pregnancy. Arch Dis Child. 1991; 66:62-5.
4. 4. Koch S, Loesche G, Jager Roman E, et al. Major birth malformations and antiepileptic drugs. Neurology. 1992;42(Suppl 5):83-8.
5. 5. Lindhout D, Meinardi H, Meijer JWA, et al. Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy, paralleled by changes in pattern of malformations. Neurology Suppl. 1992;42:94-110.
6. 6. Nakeno Y, Kaneko S. Congenital anomalies in the offspring of epileptic mothers. Cong Anom. 1992;32:309-21.
7. 7. Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet. 1982;2:937.
8. 8. Hanson JW, Ardinger HH, Di Liberty J, et al. Effects of valproic acid on the fetus. Pediatr Res. 1984;18:306A.
9. 9. Tein I, MacGregor DL. Possible valproate teratogenicity. Arch Neurol. 1985;42:291-93.
10. 10. Robert E, Rosa F. Valproate and birth defects. Lancet. 1983;2: 1142.
11. 11. Lammer EJ, Sever LE, Oakley GP Jr. Teratogen update: Valproic acid. Teratology. 1987;35:465-73.
12. 12. Lindhout D, Schmidt D. In utero exposure to valproate and neural tube defects. Lancet 1986;1:1392-93.
13. 13. Kao J, Brown NA, Schmids B, Goulding EH, Fabro S. Teratogenicity of valproic acid in vivo and in vitro investigations. Teratogenesis Carcinog Mutagen. 1981;1:367-82.
14. 14. Ong LI, Schardein JL, Petrere JA, et al., Teratogenesis of calcium valproate in rats. Fundam Appl Toxicol. 1983;3:121-26.
15. 15. Nau H, Loscher W. Pharmacologic evaluation of various metabolites and analogues of valproic acid: teratogenic potencies in mice. Fundam Appl Toxicol. 1986;6:669-76.
16. 16. Naruse I, Collins MD, Scott WJ Jr. Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos. Teratology. 1988;38:87-96.
17. 17. Paulson RB, Sucheston ME, Hayes TG, Paulson GW. Teratogenic effects of valproate in the CD-1 mouse fetus. Arch Neurol. 1985; 42:980-83.
18. 18. Padmanabhan R, Hameed MS. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse. J Craniofac Genet Dev Biol. 1994;14:192-205.
19. 19. Ehlers K, Sturje H, Merker HJ, Nau H. Valproic acid induced spina bifida: A mouse model. Teratology. 1992;45:145-54.
20. 20. Padmanabhan R, Vaidhya HR. Neural tube defects in curly tail mice: Effects of administration of sodium valproate. Teratology. 1990;42:25A.
21. 21. Sever LE, Strassburg MA. Epidemiologic aspects of neural tube defects in the United States: Changing concepts and their importance for screening and prenatal diagnostic programs. In: Miejewski GJ, Porter IH, eds. Alpha-fetoprotein and congenital disorders. New York: Academic Press; 1985:243-62.
22. 22. Buehler BA, Delimont D, Van Waer M, Finnel RH. Prenatal prediction of risk of fetal hydantoin syndrome. N Engl J Med. 1990; 322:1567-72.
23. 22. Khoury MJ, Erickson JD, James LM. Etiologic heterogeneity of neural tube defects. I Clues from epidemiology. Am J Epidemiol. 1982;115:538-48.
24. 23. Khoury MJ, Erickson JD, James LM. Etiologic heterogeneity of neural tube defects. II. Clues from family studies. Am J Hum Genet. 1982;34:980-87.
25. 24. Copp AJ, Brook FA, Estibeiro JP, Shun ASW, Cockraft DL. The embryonic development of mammalian neural tube defects. Prog Neurobiol. 1990;35:363-403.
26. 25. Sulik KK, Sadler TW. Postulated mechanisms underlying the development of neural tube defects: Insight from in vitro and in vivo studies. Ann NY Acad Sci. 1993;678:8-21.
27. 26. Khoury MJ, James LM, Flanders WD, Erickson JD. Interpretation of recurring weak associations obtained from epidemiological studies of suspected human teratogens. Teratology. 1992;46:69-77.
28. 27. Finnel RH, Bennet GD, Karras SB, Mohl VA . Common hierarchies of susceptibility to the induction of neural tube defects in the mouse embryos by valproic acid and its 4-propyl-4 pentanoic acid metabolite. Teratology. 1988;38:313-28.
29. 28. Naruse I, Collins MD, Scott WJ. Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos. Teratology. 1988;38:87-96.
30. 29. Dempsey EE, Trasler DG. Early morphological abnormalities in Splotch mouse embryos and predisposition to gene- and retinoic acid-induced neural tube defects. Teratology. 1983;28:461-72.
31. 30. Venkemans M, Fraser FC. Stages of palate closure as an indication of liability to cleft palate. Am J Med Genet. 1979;4:95-102.
32. 31. Seller MJ, Perkins KJ. Effect of mitomycin C on the neural tube defects of the curly tail mouse. Teratology. 1986;33:305-9.
33. 32. Kapron-Bras MC, Trasler DG. Histological comparison of the effects of the Splotch gene and retinoic acid on the closure of the mouse neural tube. Teratology. 1988;37:389-99.
34. 33. Tom C, Juriloff DM, Harris MJ. Studies of the effects of retinoic acid on anterior neural tube closure in mice genetically liable to exencephaly. Teratology. 1991;43:27-40.
35. 34. Padmanabhan R, Wasfi IA, Craigmyle MBL. Effect of pretreatment with aspirin on alcohol-induced neural tube defects in the TO mouse fetuses. Drug Alcohol Depend. 1994;36:175-86.
36. 35. Sterz H, Lehmann H. A critical comparison of the freehand razor blade dissection method according to Wilson with an in situ sectioning method for rat fetuses. Teratogenesis Carcinog Mutagen. 1985;5:347-54.
37. 36. Inouye M. Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red-S. Cong Anom. 1976;16:171-3.
38. 37. Elzey FF. Introductory statistics: A microcomputer approach. Adopted for IBM-PC by RD Cloward. Monterey, CA: Brooks/Cole Publishing Co.; 1987.
39. 38. Sellers MJ. Recent development in the etiology of neural tube defects. Clin Dysmorph. 1995;4:93-104.
40. 39. Lemire RJ. Anencephaly. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology, vol 6 [50 revised series] Malformation. Amsterdam: Elsevier Sci Publ BV; 1987:71-95.
41. 40. Lemire RJ, Siebert JR. Anencephaly: Its spectrum and relationship to neural tube defects. J Craniofac Genet Dev Biol. 1990;10:163-74.
42. 41. Padmanabhan R. Experimental induction of cranioschisis aperta and exencephaly after neural tube closure: A rat model, J Neurol. Sci. 1984;66:235-43.
43. 42. Gardner WJ. Hypothesis: Overdistension of the neural tube may cause anomalies of nonneural organs. Teratology. 1980:22:229-38.
44. 43. Schoenwolf GC, Smith JL. Mechanisms of neurulation: traditional viewpoint and recent advances. Development. 1990; 109:243-70.
45. 44. Padmanabhan R. Light microscopic studies on the pathogenesis of exencephaly and cranioschisis induced in the rat after neural tube closure. Teratology. 1988;37:29-36.
46. 45. Padmanabhan R. Is exencephaly the forerunner of anencephaly? An experimental study on the effect of prolonged gestation on the exencephaly induced after neural tube closure in the rat. Acta Anat. 1991;141:182-92.
47. 46. Nau H. Teratogenic valproic acid concentrations: Infusion by implanted minipumps vs. conventional injection regimen in the mouse. Toxicol Appl Pharmacol. 1985;80:243-50.
48. 47. Nau H. Valproic acid teratogenicity in mice after various administration and phenobarbital pretreatment regimens: The parent drug and not one of the metabolites assayed is implicated as teratogen. Fundam Appl Toxicol 1986;6:662-8.
49. 48. Wilson JG. Environment and birth defects. New York: Academic Press; 1973.
50. 49. Seller MJ, Perkins KJ, Adinolfi M. Differential response of heterogeneous curly tail mouse embryos to vitamin A teratogenesis depending on maternal genotype. Teratology. 1983;28:123-9.
51. 50. Dagg CP, Schleger G, Doerr A. Polygenic control of teratogenicity of 5-fluorouracil in mice. Genetics 1965;53:1101-17.
52. 51. Cusic AM, Dagg CP. Spontaneous and retinoic acid-induced post-axial polydactyly. Teratology. 1985;31:49-59.
53. 52. Turner S, Sucheston ME, De Philip RM, Paulson RB. Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate. Teratology. 1990;41:421-42.
54. 53. Elmazar MMA, Vogel R, Spielmann H. Amniotic fluid cholinesterase of valproate-induced exencephaly in the mouse: An animal model for prenatal diagnosis of neural tube defects. Arch Toxicol. 1988;61:501-3.
55. 54. Strickler SM, Miller MA, Andermant E, Dansky LV, Seni MH, Spielberg SP. Genetic predisposition to phenytoin induced birth defects. Lancet. 1985;5:746-9.
56. 55. Phelan MC, Pellock JM, Nance WE. Discordant expression of fetal hydantoin syndrome in heteropaternal dizygotic twins. N Engl J Med. 1992;307:99-101.
57. 56. Sharony R, Garber A, Viskochil D et al. Preaxial ray reduction defects as part of valproic acid embryopathy. Prenat Diagn. 1993; 13:909-18.
58. 57. Denker L, Nau H, D'Argy R. Marked accumulation of valproic acid in embryonic neuroepithelium of the mouse during early organogenesis. Teratology. 1990;4:699-706.
59. 58. Althouse AL, Hitt DC. The teratogenic effects of valproic acid in human chondrogenesis in vitro. Teratology. 1994;49:208-17.
60. 59. Golden JA , Chernoff, GF. Intermittent pattern of neural tube closure in two strains of mice. Teratology. 1993;47:73-80.
61. 60. Van Allen MI, Kalousek DK, Chernoff GF, et al. Evidence for multi-site closure of neural tube in humans. Am J Med Genet. 1993;47:723-43.
62. 61. MacDonald KB, Juriloff DM, Harris MJ. Developmental study of neural tube closure in a mouse stock with a high incidence of exencephaly. Teratology. 1989; 39:195-213.
63. 62. Juriloff DM, MacDonald KB, Harris MJ. Genetic analysis of the cause of exencephaly in the SELH/Bc mouse stock. Teratology. 1989;40:395-405.
64. 63. Muller F, O'Rahilly, R. Development of anencephaly and its variants. Am J Anat. 1991;190:193-218.
65. 64. Kotch, LE, Sulik, KK. Experimental fetal alcohol syndrome: Proposed pathogenic basis for a variety of associated fetal and brain anomalies. Am J Med Genet. 1992;44:168-76.
66. 65. Seegmiller RE, Harris C, Luchtel DL , Juchau MR. Morphological differences elicited by two weak acids, retinoic and valproic, in rat embryos grown in vitro. Teratology. 1991;43:133-50.
67. 66. Marin-Padilla M. Morphogenesis of experimental encephalocele (cranioschisis occulta). J Neurol Sci. 1980;46:83-99.
68. 67. Chaurasia BD. Calvarial defects in human anencephaly. Teratology. 1984;29:165-72.
69. 68. Petrere JA, Anderson JA, Sakowski R, Fitzgerald JIE, De La Iglesia FA. Teratogenesis of calcium valproate in rabbit. Teratology. 1986;34:263-9.
70. 69. Russell LB. Sensitivity patterns for the induction of homeotic shifts in a favorable strain of mice. Teratology. 1979;20:115-26.
71. 70. Jegalian BG, De Robertis EM. Homeotic transformation in the mouse induced by overexpression of a human Hox 3.3 transgene. Cell. 1992;71:901-10.
72. 71. Kessel M, Gruss P. Homeotic transformation of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell. 1991;76:89-104.
73. 72. An I, Bennet GD, Finnell RH. Alteration in gene expression induced by valproic acid during murine neural tube closure. Teratology. 1995;51:163.
74. 73. Trotz M, Wegner C R, Nau H. Valproic acid induced neural tube defects: Reduction by folinic acid in the mouse. Life Sci. 1987; 41:103-10.